Mesoblast (NasdaqGS:MESO) 2025 Conference November 19, 2025 06:00 PM ET Company ParticipantsJim O'Brien - CFOSilviu Itescu - CEO and Managing DirectorPaul Hughes - COOConference Call ParticipantsJohn Hester - Senior AnalystPaul HughesMorning, John.John HesterOf course. Of course, Mesoblast is the global leader in allogeneic cellular medicines for inflammatory disease, and it has been a huge year for the company. Twelve months ago, we sat here, Paul, sweating on an FDA approval. Of course, that came out a fe ...